{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"authors":[{"name":"Kelsey Hickey","affiliation":"Harvard Medical School","affiliation_url":null,"username":"n4rle152x1z4ule1","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""},"note":"","is_verified_user":true},{"name":"Harper JW","affiliation":"Harvard Medical School","affiliation_url":null,"username":"harper----jw","link":null,"image":{"source":"/img/avatars/016.png","placeholder":"/img/avatars/016.png","webp_source":""},"note":"","is_verified_user":true},{"name":"Sharan Sharan Swarup","affiliation":"Harvard Medical School","affiliation_url":"","username":"sharan-swarup","link":"","image":{"source":"/img/avatars/008.png","placeholder":"/img/avatars/008.png","webp_source":""},"note":"","is_verified_user":true}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_manage_keywords":true,"can_remove_fork":true,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1691081267,"creator":{"name":"Kelsey Hickey","affiliation":"","affiliation_url":null,"username":"n4rle152x1z4ule1","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""},"badges":[{"id":4,"name":"Gold power author!","image":{"source":"/img/badges/gold.svg","placeholder":"/img/badges/gold.svg"}}],"affiliations":[]},"description":"{\"blocks\":[{\"key\":\"6ohah\",\"text\":\"This is a protocol for the immunoprecipitation of the Golgi protein YIPF3 that is GFP tagged, and probing for ATG8 protein interactions. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","disclaimer":"","document":"","documents":[],"doi":"dx.doi.org/10.17504/protocols.io.81wgbxy6qlpk/v1","doi_status":1,"ethics_statement":null,"fork_id":79788,"fork_info":{"id":79788,"title":"GFP-YIPF3 Immunoprecipitation","title_html":null,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":null,"uri":"gfp-yipf3-immunoprecipitation-cr6kv9cw","published_on":0,"modified_on":0,"version_class":0,"version_id":0,"version_code":"","version_uri":"","created_on":1680208063,"categories":null,"type_id":0,"creator":{"name":"Kelsey Hickey","affiliation":null,"affiliation_url":null,"username":"n4rle152x1z4ule1","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""}},"stats":null},"forks":[],"funders":[{"funder_name":"ASAP","grant_id":"000282"}],"groups":[{"id":8831,"uri":"asap-network","title":"ASAP Collaborative Research Network","is_public":false,"image":{"source":"https://s3.amazonaws.com/protocols-files/public/6f37aae407d1c3261f56707cf7d8e3a47c4d284af7e8d2ae19cb40776fda17a7/cj6mcz36.jpg","placeholder":"https://s3.amazonaws.com/protocols-files/public/6f37aae407d1c3261f56707cf7d8e3a47c4d284af7e8d2ae19cb40776fda17a7/cj6mcz36.jpg"},"tech_support":{"email":null,"phone":null,"use_email":false,"hide_contact":false,"url":null}}],"guid":"79B73D5A321D11EEAD800A58A9FEAC02","guidelines":"","has_references":false,"has_step_reagents":false,"has_versions":false,"id":85933,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":true,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":1147341,"journal":null,"journals":[],"keywords":"ASAPCRN","last_modified":1696447957,"link":"","location":null,"manuscript_citation":"","materials":[],"materials_text":"","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"protocol_references":"","public":true,"public_fork_note":"","published_on":1696447957,"references":[],"related_equipments":[],"related_materials":[],"reserved_doi":"10.17504/protocols.io.81wgbxy6qlpk/v1","retraction_reason":null,"samples":{},"shared_access_id":16,"show_comparison":true,"sign_info":null,"space_access":{"can_view":false,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":true,"can_get_doi":true,"can_share":false,"can_move":false,"can_move_outside":false,"can_transfer":false,"can_download":false,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"state_version_id":0,"stats":{"is_voted":false,"number_of_views":6,"number_of_steps":19,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this protocol and it's working"},"steps":[{"id":1752488,"guid":"79D1BA3C321D11EEAD800A58A9FEAC02","previous_id":null,"previous_guid":null,"section":"\u003cp\u003eHEK293 YIPF4 KO Creation\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"8fm9p\",\"text\":\"Maintain HEK293 cells in Dulbecco’ Modifies Eagles Medium (DMEM) with 10% fetal bovine serum and optional 1x penicillin-streptomycin. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1643979,"number":"1","cases":[],"critical":null},{"id":1752490,"guid":"79D27B31321D11EEAD800A58A9FEAC02","previous_id":1752489,"previous_guid":"79D20B7D321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF4 KO Creation\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"2hvl8\",\"text\":\"Individual clones were subjected to immunoblotting with anti-YIPF4 (Sino Biological 202844-T46), clones lacking the relevant protein were selected for further analysis by Sanger sequencing of the edited alleles.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1643995,"number":null,"cases":[],"critical":null},{"id":1752491,"guid":"79D2E98F321D11EEAD800A58A9FEAC02","previous_id":1752490,"previous_guid":"79D27B31321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 Double KO Creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"ckfht\",\"text\":\"For YIPF3/YIPF4 double knock-out, the following sgRNA sequence within the YIPF3 gene was designed and ordered (5’  CCATTTCGGGCGCCGCCCGC  3' ), and cloned into a pX459 vector to create pX459-gRNA-YIPF3-KO.  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9cav4\",\"text\":\"Sequence validate by Sanger sequencing.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"dujto\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2h197\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1643996,"number":null,"cases":[],"critical":null},{"id":1752492,"guid":"79D356F8321D11EEAD800A58A9FEAC02","previous_id":1752491,"previous_guid":"79D2E98F321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 Double KO Creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"dsrr\",\"text\":\"Transfect YIPF4 KO HEK293 cells with the pX459-gRNA-YIPF3-KO using Lipofectamine 3000, and select with 1.2 µg/mL of puromycin for 24-48 hours. Select monoclonal cells by limiting dilution or by cell sorting (SONY SH800S sorter) in 96 well plates. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1643999,"number":null,"cases":[],"critical":null},{"id":1752493,"guid":"79D3C549321D11EEAD800A58A9FEAC02","previous_id":1752492,"previous_guid":"79D356F8321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 Double KO Creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"cabe7\",\"text\":\"Individual clones were subjected to immunoblotting with anti-YIPF4 (Sino Biological 202844-T46) and anti-YIPF3 (Invitrogen PA566621), clones lacking the relevant protein were selected for further analysis by Sanger sequencing of the edited alleles.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644000,"number":null,"cases":[],"critical":null},{"id":1752494,"guid":"79D43533321D11EEAD800A58A9FEAC02","previous_id":1752493,"previous_guid":"79D3C549321D11EEAD800A58A9FEAC02","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644001,"number":null,"cases":[],"critical":null},{"id":1752495,"guid":"79D4A148321D11EEAD800A58A9FEAC02","previous_id":1752498,"previous_guid":"79D6274C321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 double KO creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"2k26m\",\"text\":\"For YIPF3/YIPF4 double knock-out, the following sgRNA sequence was designed and ordered within YIPF3  (5’ GCGTACAAGCTGAAGGCCC 3' ), and cloned into a pX459 vector to create pX459-gRNA-YIPF3-KO.  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644007,"number":"2","cases":[],"critical":null},{"id":1752496,"guid":"79D54CF0321D11EEAD800A58A9FEAC02","previous_id":1752488,"previous_guid":"79D1BA3C321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF4 KO Creation\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"6962l\",\"text\":\"For YIPF4 knock-out, the following sgRNA sequences were designed and ordered within YIPF4 (5’  ATCTCGCGGCGACTCCCAAC 3' / 5’ CGGCCTATGCCCCCACTAAC 3' ), and cloned into a pX459 vector to create pX459-gRNA-YIPF4-KO.  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644008,"number":"1.1","cases":[],"critical":null},{"id":1752497,"guid":"79D5BA5E321D11EEAD800A58A9FEAC02","previous_id":1752496,"previous_guid":"79D54CF0321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF4 KO Creation\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"53c3b\",\"text\":\"Transfect HEK293 cells with the pX459-gRNA-YIPF4-KO with Lipofectamine 3000, and select with 1.2 µg/mL of puromycin for 24-48 hours. Select monoclonal cells by limiting dilution or by cell sorting (SONY SH800S sorter) in 96 well plates.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644009,"number":"1.2","cases":[],"critical":null},{"id":1752498,"guid":"79D6274C321D11EEAD800A58A9FEAC02","previous_id":1752497,"previous_guid":"79D5BA5E321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF4 KO Creation\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"apvq3\",\"text\":\"Individual clones were subjected to immunoblotting with anti-YIPF4 (Sino Biological 202844-T46), and clones lacking the relevant protein were selected for further analysis by Sanger sequencing of the edited alleles.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644010,"number":"1.3","cases":[],"critical":null},{"id":1752499,"guid":"79D6938B321D11EEAD800A58A9FEAC02","previous_id":1752495,"previous_guid":"79D4A148321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 double KO creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"b16re\",\"text\":\"Transfect YIPF4 KO HEK293 cells with the pX459-gRNA-YIPF3-KO with Lipofectamine 3000, and select with 1.2 µg/mL of puromycin for 24-48 hours. Select monoclonal cells by limiting dilution or by cell sorting (SONY SH800S sorter) in 96 well plates.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644011,"number":"2.1","cases":[],"critical":null},{"id":1752500,"guid":"79D6FFF7321D11EEAD800A58A9FEAC02","previous_id":1752499,"previous_guid":"79D6938B321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 double KO creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"6vkd9\",\"text\":\"Individual clones were subjected to immunoblotting with anti-YIPF3 (Invitrogen PA566621), and clones lacking the relevant protein were selected for further analysis by Sanger sequencing of the edited alleles.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644012,"number":"2.2","cases":[],"critical":null},{"id":1752501,"guid":"79D76D52321D11EEAD800A58A9FEAC02","previous_id":1752500,"previous_guid":"79D6FFF7321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eHEK293 YIPF3/YIPF4 double KO creation\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644013,"number":"2.3","cases":[],"critical":null},{"id":1752502,"guid":"79D7D8C6321D11EEAD800A58A9FEAC02","previous_id":1752501,"previous_guid":"79D76D52321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eIP\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"dalhk\",\"text\":\"DKO (YIPF3/4) HEK293 cells were reconstituted with mCherry-YIPF4 (WT or LIR mutant) and GFP-YIPF3 (WT or LIR mutant) constructs and sorted for equal expression levels. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3nqre\",\"text\":\"Immunofluorescence was used to confirm proper localization of both YIPF3 and YIPF4\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644014,"number":"3","cases":[],"critical":null},{"id":1752503,"guid":"79D84C34321D11EEAD800A58A9FEAC02","previous_id":1752502,"previous_guid":"79D7D8C6321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eIP\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"5in9m\",\"text\":\"cells were plated on 10cm plates and grown to 70% confluency. Cells were left untreated or starved using AA withdrawal for 2 hours in the presence of BafA (100nm)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644015,"number":"3.1","cases":[],"critical":null},{"id":1752504,"guid":"79D8BA73321D11EEAD800A58A9FEAC02","previous_id":1752503,"previous_guid":"79D84C34321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eIP\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"7l91\",\"text\":\"Cells were washed 2x with cold PBS then lysed in 0.8mL of NP-40 lysis buffer (100mM TRIS pH7.4, 150mM KCL, 0.1% NP-40, 0.5mM EDTA, 1x HALT (Roche) protease inhibitors, phos-STOP tabs)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644016,"number":"3.2","cases":[],"critical":null},{"id":1752505,"guid":"79D92535321D11EEAD800A58A9FEAC02","previous_id":1752504,"previous_guid":"79D8BA73321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eIP\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"am8a0\",\"text\":\"1.5mg of protein from each sample was added to 15ul of washed GFP-TRAP beads and incubated for 2 hours while rotating at 4 degrees. Beads were washed 3 times with lysis buffer and eluted in 1x LDS loading dye at 94 degrees for 5 minutes\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644017,"number":"3.3","cases":[],"critical":null},{"id":1752506,"guid":"79D99035321D11EEAD800A58A9FEAC02","previous_id":1752505,"previous_guid":"79D92535321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eIP\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":true,"step":"","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644018,"number":"3.4","cases":[],"critical":null},{"id":1752507,"guid":"79D9FACB321D11EEAD800A58A9FEAC02","previous_id":1752506,"previous_guid":"79D99035321D11EEAD800A58A9FEAC02","section":"\u003cp\u003eIP\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":true,"step":"","data":null,"protocol_id":85933,"case_id":0,"critical_ids":"","duration":0,"original_id":1644019,"number":"3.5","cases":[],"critical":null}],"template_id":4,"title":"GFP-YIPF3 Immunoprecipitation V2","title_html":"GFP-YIPF3 Immunoprecipitation V2","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0,"read_only":0},{"id":2,"type_id":3,"name":"mL","can_manage":0,"read_only":0},{"id":3,"type_id":3,"name":"L","can_manage":0,"read_only":0},{"id":4,"type_id":3,"name":"µg","can_manage":0,"read_only":0},{"id":5,"type_id":3,"name":"mg","can_manage":0,"read_only":0},{"id":6,"type_id":3,"name":"g","can_manage":0,"read_only":0},{"id":7,"type_id":3,"name":"kg","can_manage":0,"read_only":0},{"id":8,"type_id":3,"name":"ng","can_manage":0,"read_only":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0,"read_only":0},{"id":10,"type_id":24,"name":"°C","can_manage":0,"read_only":0},{"id":11,"type_id":24,"name":"°К","can_manage":0,"read_only":0},{"id":12,"type_id":24,"name":"°F","can_manage":0,"read_only":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0,"read_only":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0,"read_only":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0,"read_only":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0,"read_only":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0,"read_only":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0,"read_only":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0,"read_only":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0,"read_only":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":1},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0,"read_only":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0,"read_only":0},{"id":24,"type_id":3,"name":"μV","can_manage":0,"read_only":0},{"id":25,"type_id":3,"name":"ms","can_manage":0,"read_only":0},{"id":26,"type_id":3,"name":"pg","can_manage":0,"read_only":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0,"read_only":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0,"read_only":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0,"read_only":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0,"read_only":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0,"read_only":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0,"read_only":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0,"read_only":0},{"id":34,"type_id":30,"name":"x g","can_manage":0,"read_only":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0,"read_only":0},{"id":200,"type_id":32,"name":"cm","can_manage":0,"read_only":0},{"id":201,"type_id":32,"name":"mm","can_manage":0,"read_only":0},{"id":202,"type_id":32,"name":"µm","can_manage":0,"read_only":0},{"id":203,"type_id":32,"name":"nm","can_manage":0,"read_only":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0,"read_only":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0,"read_only":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0,"read_only":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0,"read_only":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0,"read_only":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0,"read_only":0}],"uri":"gfp-yipf3-immunoprecipitation-v2-cx6mxrc6","url":"https://www.protocols.io/view/gfp-yipf3-immunoprecipitation-v2-cx6mxrc6","version_class":85933,"version_data":{"id":0,"code":"cx6mxrc6","version_class":85933,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"version_id":0,"version_uri":"gfp-yipf3-immunoprecipitation-v2-81wgbxy6qlpk/v1","versions":[{"id":85933,"title":"GFP-YIPF3 Immunoprecipitation V2","title_html":"GFP-YIPF3 Immunoprecipitation V2","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.81wgbxy6qlpk/v1","uri":"gfp-yipf3-immunoprecipitation-v2-cx6mxrc6","published_on":1696447957,"modified_on":1696447957,"version_class":85933,"version_id":0,"version_code":"cx6mxrc6","version_uri":"gfp-yipf3-immunoprecipitation-v2-81wgbxy6qlpk/v1","created_on":1691081267,"categories":null,"type_id":1,"creator":{"name":"Kelsey Hickey","affiliation":null,"affiliation_url":null,"username":"n4rle152x1z4ule1","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}